I would be very careful about trying to guess what side effects seti should or shouldn't be producing.
PGD synthetase, the enzyme that creates PGD2, is
most highly abundant in rat brains and spinal cords. There is dramatically more of it in the brain and spine
than anywhere else in the body:
View attachment 85843
It's expressed pretty evenly throughout every area of the brain:
View attachment 85844
What does all this PGD2 do in the brain?
No one knows.
Furthermore, the very same receptor that seti blocks is involved in mood related functions of rats:
CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice.
Depression is a complex neuropsychiatric disorder with an unclear molecular etiology. Inflammatory cytokines and molecular intermediates (including prostaglandins) are suggested to be involved in depression; however, the roles of prostaglandins and their respective receptors are largely unknown in depression. Using genetic and pharmacological approaches, we show here that chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2), a second receptor for prostaglandin D2 (PGD2), mediates depression-related behavior in mice. CRTH2-deficient (CRTH2(-/-)) mice showed antidepressant-like activity in a chronic corticosterone treatment-induced depression. Consistent with this observation, the pharmacological inhibition of CRTH2 via the clinically available drug ramatroban also rescued abnormal social interaction and depression-related behavior in well-established models, including chronic corticosterone-, lipopolysaccharide-, and tumor-induced pathologically relevant depression models. Importantly, chronic stress via corticosterone treatment increased mRNA levels in PGD2-producing enzymes, such as cyclooxygenase-2 and lipocalin-type PGD2 synthase, in the brain. Furthermore, the activity of the hippocampal noradrenergic system but not the dopaminergic or serotonergic systems was increased in CRTH2(-/-) mice. Together with the observation that untreated CRTH2(-/-) mice showed antidepressant-like activity in the forced swim test, these results provide evidence that central CRTH2-mediated signaling is critically involved in depression-related behavior.
https://www.ncbi.nlm.nih.gov/pubmed/25698598
In that study, they found mice that don't have this receptor for PGD2 were protected against depression. What will blocking it do to human moods?
This is such an incredibly experimental compound and pathway to manipulate. The truth is you really have absolutely no idea what you're doing to your brain with it.
I think these compounds would be easier to rationalize if they were topical. But seti makes a terrible topical from what I understand. I've heard fevi makes a better topical. Is that true? If so, why aren't people trying to do that instead? Why nuke the PGD2 in your brain with massive oral doses?